Tradovate is pleased to announce a partnership with Order Flow Analytics to offer its popular order flow analysis, volume visualization, and algo trading tools on Tradovate’s platform. This marks the first time that OFA’s software is fully integrated with a platform, eliminating the need for a separate installation and making for a more seamless trading experience. Try a Free 14-day trial of Tradovate to use with OFA today >> OFA customers on Tradovate get: OFA Charts to analyze order flow, visualize volume, and apply proprietary indicators OFA/AlgoX to create, execute, and manage custom algos for automated trade and risk management OFA/AlgoX algos managed server-side, taking computer crashes and internet disruptions out of the equation Unlimited commission-free trading, starting at $39 per month. No hidden fees or catches; just simple, transparent pricing Trade and access OFA from desktop (Windows & Mac) and web browser (Google Chrome and others) plus get Tradovate's mobile apps for phone & tablet (iPhone, iPad and Android) - all included at no extra cost. No platform licensing fees, order routing fees, or mobile app fees $500 day trading margins for E-mini S&P 500, Nasdaq 100, Dow & Mini-Russell 2000 No inactivity fees No volume requirements $1,000 account minimum How Tradovate’s commission-free pricing works Instead of charging a commission for every contract you trade, we charge a flat price for membership, starting at $39 per month. Trade as much or as little as you want and never pay a per-trade commission. When you do trade, you simply pay the exchange & NFA fees you pay at every broker and a small $0.09 per contract clearing fee. For example, Tradovate members trading the e-mini S&P 500 contract would pay $1.18 for exchange fees, $0.01 for NFA fees, and $0.09 for clearing fees, bringing the total cost to $1.28 per contract or $2.56 round turn. That’s it. Get Started with OFA on Tradovate Now >> Futures and options trading involves substantial risk of loss and is not suitable for all investors. Past performance is not necessarily indicative of future results.